Abstract | BACKGROUND: METHODS: Seventy-four patients who were candidates for rhinoplasty were randomly divided into three groups. Group A received 8 mg of i.v. dexamethasone preoperatively and again after 24 and 48 hours after surgery, group B received three pseudoephedrine tablets (60 mg) per day for 1 week, and group C received three pseudoephedrine tablets (60 mg) per day for 2 weeks. Finally, their effects on the eye, tip and dorsal edema, and ecchymosis were evaluated. RESULTS: CONCLUSION:
|
Authors | Babak Saedi, Mohammad Sadeghi, Khaveh Fekri |
Journal | American journal of rhinology & allergy
(Am J Rhinol Allergy)
2011 Jul-Aug
Vol. 25
Issue 4
Pg. e141-4
ISSN: 1945-8932 [Electronic] United States |
PMID | 21819749
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Nasal Decongestants
- Pseudoephedrine
- Dexamethasone
|
Topics |
- Adult
- Dexamethasone
(administration & dosage, adverse effects)
- Ecchymosis
(drug therapy, etiology)
- Edema
(drug therapy, etiology)
- Eyelids
(drug effects, pathology)
- Female
- Follow-Up Studies
- Humans
- Male
- Nasal Decongestants
(administration & dosage, adverse effects)
- Nasal Septum
(drug effects, pathology, surgery)
- Postoperative Complications
- Pseudoephedrine
(administration & dosage, adverse effects)
- Rhinoplasty
- Surgery, Plastic
|